NCAA president Mark Emmert should immediately reconsider his decision regarding Kolton Houston's eligibility.
Here the facts:
Houston has never played a down in college. He arrived in Athens early as a freshman following shoulder surgery and tested positive for the anabolic steroid Norandrolone. This failed test for PEDs brought on a one-year suspension, which he served in year one.
The following February, Houston failed a drug test once again for the same exact substance and was immediately ruled permanently ineligible by the NCAA. The school appealed this ruling providing copious results from self-administrated drug tests that demonstrated the amounts in Houston’s system had been gradually decreasing (or at least they plateaued.)
With detailed testing provided, the NCAA ruled in favor of Georgia and removed “permanent” from Houston’s ineligibility. The problem, however, was that the drug was still present so they replaced the terminology with “indefinite” instead. Because he still had traces of the steroid, he was not allowed to see the field per the NCAA’s drug policy.
Another year later and Houston is once again ineligible as remnants of the drug remain. His test results have continued to decrease—albeit very slowly—but the NCAA hasn’t budged.
[Your Best 11]
Emmert is taking an unnecessarily hard line in this case. There is ample medical and scientific evidence that Houston has not used PEDs since the incident that caused the initial positive test. The purpose of the rule is to prevent college athletes from attaining a competitive advantage through the use of PEDs.
In the case of Mr. Houston - mission accomplished.